Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19
10/7/2021
0:00
17:22
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
More episodes from "Coronavirus (COVID-19) Q&A"
Don't miss an episode of “Coronavirus (COVID-19) Q&A” and subscribe to it in the GetPodcast app.